Ngā hua rapu - Nicolas Moosmann
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal tran... mā Sebastian Stintzing, Christine Kapaun, Rüdiger P. Laubender, Andreas Jung, Jens Neumann, Dominik Paul Modest, Clemens Gießen, Nicolas Moosmann, Andreas Wollenberg, Thomas Kirchner, Volker Heinemann
I whakaputaina 2012Artigo -
2
Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK... mā Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser, Martina Stauch, Holger G. Hass, H Dietzfelbinger, Daniel Oruzio, Stefan Klein, Klaus Zellmann, Thomas Decker, Mathias Schulze, Wolfgang Abenhardt, Gerhard Puchtler, Herbert Kappauf, J. Mittermüller, C. Haberl, Andreas Schalhorn, Andreas Jung, Sebastian Stintzing, Volker Heinemann
I whakaputaina 2011Artigo -
3
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial mā Beate Rau, Hauke Lang, Alfred Koenigsrainer, Ines Gockel, Horst-Guenter Rau, Hendrik Seeliger, C. Lerchenmueller, Daniel Reim, Roger Wahba, Martin K. Angele, Steffen Heeg, Tobias Keck, Arved Weimann, Stefan A. Topp, Pompiliu Piso, Andreas Brandl, Silke Schuele, Peter Jo, Johann Pratschke, Sandra Wegel, Alexander Rehders, Nicolas Moosmann, Jochen Gaedcke, Volker Heinemann, Evelyn Trips, Markus Loeffler, Peter M. Schlag, Peter Thuss‐Patience
I whakaputaina 2023Artigo -
4
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer mā Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat, Günther Klautke, Gerhard G. Grabenbauer, Rainer Fietkau, Thomas Kuhnt, Ludger Staib, Thomas Brunner, Anca‐Ligia Grosu, Simon Kirste, Lutz Jacobasch, Michael Allgäuer, Michael Flentje, Christoph‐Thomas Germer, Robert Grützmann, Guido Hildebrandt, Matthias Schwarzbach, Wolf O. Bechstein, Heiko Sülberg, Tim Friede, Jochen Gaedcke, Michael Ghadimi, Ralf‐Dieter Hofheinz, Claus Rödel, Detlef Imhoff, Guido Woeste, Nils Habbe, Ursula Pession, Martin‐Leo Hansmann, Peter J. Wild, Stephan Falk, Petra Hödl, A Serebrennikov, Sanja Schmeck, Vittorio Paolucci, Stephan Sahm, Martin Eichel, Giovanna Römer, W. Bank, Nicolas Moosmann, Jan Braess, P. Piso, Heinrich Wiesinger, Peter Kappl, Elisabeth Germer, Monika Warmuth‐Metz, Volker Kunzmann, Katica Krajinovic, Andreas Rosenwald, Thorsten Alexander Bley, Ulrich Stölzel, Manfred Dörne, L. Renziehausen, Joachim Boese-Land, Dietrich Meißner, D. Burchert, Olaf Dirsch, Jörg Olaf Habeck, Klaus Kirchhof, Christof Lamberti, B. J. Leibl, Andreas Gschwendtner, Godehard Lahmer, Marga Lang-Welzenbach, Werner Hohenberger, Thomas Kuhnt, Kirsten Papsdorf, Christian Wittekind, Christine Volkheimer, Frederik Wenz, Kirsten Merx, Stefan Post, Timo Gaiser, Ulrike Attenberger, Michael Geißler, Jörn Sträter, Helmut Gnann, Stefan Krämer, Michael Henke, Henning Schäfer, Philipp Manegold, Hannes Neeff, Peter Bronsert, Wolff Schmiegel, Michael Pohl, Christian Möllecken, Irenäus A. Adamietz, Richard Viehbahn, Andrea Tannapfel, Jens Freiberg‐Richter, Thorsten Jacobi, Wolfgang Wendt, Klaus Holzweißig, Thomas Kittner, Ullrich Graeven, Christiane Lange, U. Kania, Elisabeth Rösler, Harold Ortloff
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Internal medicine
Medicine
Oncology
Colorectal cancer
Randomized controlled trial
Capecitabine
Cetuximab
Chemotherapy
Clinical endpoint
Environmental health
Irinotecan
KRAS
Oxaliplatin
Population
Surgery
Breast cancer
Chemoradiotherapy
Cisplatin
Cytoreductive surgery
Epidermal growth factor receptor
Fluorouracil
Gastroenterology
Hyperthermic intraperitoneal chemotherapy
Induction chemotherapy
Metastasis
Mitomycin C
Neoadjuvant therapy
Ovarian cancer
Perioperative